Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients

NCT01734694 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT01734694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01734694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients
Lead sponsor
Henry Ford Health System
Phase
Phase 4
Overall status
Terminated
Start date
October 31, 2011
Completion date
September 30, 2012
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute bacterial skin and skin structure infections, bacteremia, endocarditis, health care associated pneumonia, osteomyelitis/septic arthritis